14-day Premium Trial Subscription Sign Up For FreeGet Free

Antares Pharma Stock Forecast NASDAQ:ATRS

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "HC Wainwright" gave "$5.00 - $5.50" rating for ATRS. The price target was changed from $4.23 to 0.7%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-06 $5.00 - $5.50 Target Raised by HC Wainwright $4.10 $4.23→0.7%
2021-07-16 $7.00 Initiated by Truist Financial $4.15 $4.22+2.4%
2021-07-16 $7.00 Initiated by Truist Securities $4.15 $4.12→3.5%
2021-07-16 $7.00 Initiated by Truist $4.15 $4.12→3.5%
2021-05-17 Buy Target Raised by HC Wainwright $4.04 $4.50 → $5.00
2021-05-10 Buy Target Raised by HC Wainwright $3.80 $4.50 → $5.00
2021-05-10 Buy Reiterated by HC Wainwright $3.80 $5.00
2020-10-01 Buy Reiterated by Raymond James $2.84
2020-09-15 Buy Reiterated by Raymond James $2.75 $6.00
2020-08-24 Buy Reiterated by Raymond James $2.61
2020-08-17 Buy Reiterated by Raymond James $2.94
2020-08-10 Buy Reiterated by HC Wainwright $3.06
2020-06-21 Overweight Reiterated by Piper Sandler $2.90 $5.00
2020-06-21 Buy Reiterated by LADENBURG THALM/SH SH $2.90 $7.00
2020-05-06 Buy Target Lowered by HC Wainwright $2.71 $5.00 → $4.50

ATRS Stock Trend

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.58 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -16.57% during the next 3 months and, with a 90% probability hold a price between $2.99 and $3.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $3.57 $3.79 $4.01
2021-09-23 $3.56 $3.78 $3.99
2021-09-24 $3.55 $3.76 $3.98
2021-09-27 $3.53 $3.75 $3.97
2021-09-28 $3.52 $3.74 $3.96
2021-09-29 $3.51 $3.73 $3.94
2021-09-30 $3.50 $3.71 $3.93
2021-10-01 $3.48 $3.70 $3.92
2021-10-04 $3.47 $3.69 $3.91
2021-10-05 $3.46 $3.68 $3.89
2021-10-06 $3.45 $3.66 $3.88
2021-10-07 $3.43 $3.65 $3.87
2021-10-08 $3.42 $3.64 $3.85
2021-10-11 $3.41 $3.62 $3.84
2021-10-12 $3.39 $3.61 $3.83
2021-10-13 $3.38 $3.60 $3.82
2021-10-14 $3.37 $3.59 $3.80
2021-10-15 $3.36 $3.57 $3.79
2021-10-18 $3.34 $3.56 $3.78
2021-10-19 $3.33 $3.55 $3.77
2021-10-20 $3.32 $3.54 $3.75
2021-10-21 $3.31 $3.52 $3.74
2021-10-22 $3.29 $3.51 $3.73
2021-10-25 $3.28 $3.50 $3.71
2021-10-26 $3.27 $3.49 $3.70
2021-10-27 $3.26 $3.47 $3.69
2021-10-28 $3.24 $3.46 $3.68
2021-10-29 $3.23 $3.45 $3.66
2021-11-01 $3.22 $3.43 $3.65
2021-11-02 $3.20 $3.42 $3.64

About Antares Pharma

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; ZOMA-Jet and Twin-Jector, a needle-free a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT